Illumina, Inc. (ILMN) FY2024 YTD Q3 P&L / Income Statement

Illumina, Inc. (ILMN) FY2024 YTD Q3 P&L / Income Statement

Income statement for 2024-01-01 through 2024-09-29. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

3,268,000,000 US dollars

Total cost of revenue

1,135,000,000 US dollars

Gross profit

2,133,000,000 US dollars

Total operating expense

3,141,000,000 US dollars

Income (loss) from operations

negative 1,008,000,000 US dollars

Total other expense, net

negative 358,000,000 US dollars

Income (loss) before income taxes

negative 1,366,000,000 US dollars

Provision (benefit) for income taxes

44,000,000 US dollars

Net income (loss)

negative 1,410,000,000 US dollars

Microarray - Consumables

216,000,000 US dollars

Microarray - Instruments

12,000,000 US dollars

Microarray - Service

51,000,000 US dollars

Sequencing - Consumables

2,160,000,000 US dollars

Sequencing - Instruments

330,000,000 US dollars

Sequencing - Service

499,000,000 US dollars

Research and development

913,000,000 US dollars

Selling, general and administrative

813,000,000 US dollars

Legal contingency and settlement

negative 474,000,000 US dollars

Goodwill and intangible impairment

1,889,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.